Tharimmune
(NASDAQ) HILS
Tharimmune Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$11.85M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
HILS News
HILS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Tharimmune
Industry
Biotechnology
Sector
Health CareEmployees
2
CEO
Sireesh Appajosyula, PhD
Website
tharimmune.comHeadquarters
Bridgewater, NJ 08807, US
HILS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-7%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$12.43M
EBITDA
$12.43M
Operating Cash Flow
$10.90M
Capital Expenditure
$0.00
Free Cash Flow
$10.90M
Cash & ST Invst.
$3.56M
Total Debt
$0.00
Tharimmune Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
1
N/A
Net Income
$2.10M
+44.6%
EBITDA
$2.07M
+46.5%
Quarterly Fundamentals
Net Cash
$7.61M
+59.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.54%
N/A
Return on Invested Capital
-1.95%
N/A
Free Cash Flow
$1.86M
+35.2%
Operating Cash Flow
$1.86M
+35.2%